Skip to main content

Author: Customer Service

Sunlands Technology Group Announces Unaudited Third Quarter 2025 Financial Results

BEIJING, Nov. 20, 2025 (GLOBE NEWSWIRE) — Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial and Operational SnapshotsNet revenues were RMB523.0 million (US$73.5 million), compared to RMB491.3 million in the third quarter of 2024. Gross billings (non-GAAP) were RMB349.2 million (US$49.0 million), compared to RMB360.3 million in the third quarter of 2024. Gross profit was RMB462.7 million (US$65.0 million), compared to RMB409.2 million in the third quarter of 2024. Net income was RMB125.4 million (US$17.6 million), compared to RMB89.3 million in the third quarter of 2024. Net income margin1...

Continue reading

UP Fintech Holding Limited to Report Third Quarter 2025 Financial Results on December 4, 2025

SINGAPORE, Nov. 20, 2025 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading online brokerage firm focusing on global investors, today announced that it will report its financial results for the third quarter ended September 30, 2025, before the U.S. market opens on December 4, 2025. UP Fintech’s management will hold an earnings conference call at 8:00 AM on December 4, 2025, U.S. Eastern Time (9:00 PM on December 4, 2025, Singapore/Hong Kong Time). Conference Call Information: All participants wishing to attend the call must preregister online before they may receive the dial-in numbers. Preregistration may require a few minutes to complete. Preregistration Information: Please note that all participants will need to pre-register for the conference call, using the link:  https://register-conf.media-server.com/register/BI3699a7be25e74cd7b11ddad5ba85161d It...

Continue reading

Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcements by Hofseth BioCare ASA (“HBC” or the “Company”) on 7 November 2025 regarding the terms of a subsequent offering of up to 16,666,666 new shares (the “Offer Shares”) in the Company (the “Subsequent Offering”) and on 10 November 2025 regarding the start of the subscription period in the Subsequent Offering. Each Offer Share is offered at a subscription price of NOK 1.80. The subscription period for the Subsequent Offering...

Continue reading

Rocket Lab to Launch Second Mission in 48 Hours

LONG BEACH, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the launch of its next Electron mission is scheduled to take place from Rocket Lab Launch Complex 1 in New Zealand – less than 48 hours after the successful launch of an earlier mission from Rocket Lab Launch Complex 2 in Virginia. The mission, named ‘Follow My Speed’, is scheduled for liftoff during a launch window that opens on November 20, 2025 from 12:15 UTC to deploy a single satellite for a confidential commercial customer. The launch window opens just 48 hours after Rocket Lab successfully completed its latest HASTE mission and 75th launch to date. With that mission Rocket Lab bested its previous annual launch record of 16 missions....

Continue reading

Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE

Hofseth BioCare (HBC), a global leader in sustainable marine-based nutrition, today announced a strategic product partnership with Metabolic Elite, with formulations being guided by key opinion leader and nutrition expert Jim LaValle. The collaboration unites HBC’s rigorously tested nutritional ingredients, including award-winning ProGo® bioactive peptides, with Metabolic Elite’s advanced performance formulations and LaValle’s expertise in precision health. Together they will develop a premium range of performance nutrition products for elite athletes to:Enhance athletic performance through improved recovery, endurance, and metabolic efficiency. Support precision health by addressing individual metabolic needs with targeted nutrition. Promote sustainability by leveraging HBC’s eco-friendly production...

Continue reading

Renewable power: STMicroelectronics and TSE sign 15-Year PPA to power French sites with solar energy

Renewable power: STMicroelectronics and TSE sign 15-Year PPAto power French sites with solar energy 15-year contract for TSE to supply approximately 780 GWh of renewable electricity from three solar parks (43 MW total) to STMicroelectronics’ sites in France starting in 2027.  Paris, France; Geneva, Switzerland — 20 November 2025 — TSE, a leading player in solar energy and agrivoltaics in France, and STMicroelectronics (NYSE:STM), a global semiconductor leader serving customers across the spectrum of electronics applications, have signed a physical Power Purchase Agreement (PPA) to supply renewable electricity from solar parks to STMicroelectronics’ sites in France. TSE will supply STMicroelectronics with renewable power generated by three solar parks in France, operated by TSE, totaling approximately 43 MW. This 15-year contract,...

Continue reading

Michelin: Disclosure of trading in own shares – November 20th, 2025

23, Place des Carmes-Déchaux – 63000 CLERMONT-FERRAND Information about securities repurchasing programRegulated informationIssuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of securities: ordinary shares – Code ISIN FR001400AJ45Date : November 20th, 2025Issuer Name Issuer code Transactiondate ISIN Code Daily total volume (in number of actions) Daily weighted average price of shares acquired PlatformCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 20.11.2025 FR001400AJ45 876 761 28,514 euros Over-the-counterCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 20.11.2025 FR001400AJ45 876 761 28,514 euros Over-the-counterIssuer Name Issuer code PSIName Issuer Code Transaction date   ISIN Code Unit Price Currency Quantity bought Platform Transaction reference number Buyback...

Continue reading

Inside information: KH Group has sold its shares in Indoor Group and agreed on financing arrangements related to the sale

KH Group PlcInside information 20 November 2025 at 9:45 am EET Inside information: KH Group has sold its shares in Indoor Group and agreed on financing arrangements related to the sale KH Group Plc (“KH Group” or the “Company“) has signed an agreement to sell all its shares in Indoor Group Holding Oy (“Indoor Group“) to a company controlled by Indoor Group’s CEO Kati Kivimäki. The transaction was completed today, 20 November 2025, and with it, KH Group has achieved its strategic objective to exit its Indoor Group investment during 2025. The shares subject to the transaction comprise 58.3 per cent of all shares in Indoor Group, and a nominal purchase price has been paid to the Company for them. In addition, the Company has in connection with the transaction agreed on a financing arrangement in which Indoor...

Continue reading

Subsea 7 S.A. Announces Third Quarter 2025 Results

Luxembourg – 20 November 2025 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, ISIN: LU0075646355, the Company) announced today results of Subsea7 Group (the Group, Subsea7) for the third quarter which ended 30 September 2025. Highlights Third quarter Adjusted EBITDA of $407 million, up 27% on the prior year period, equating to a margin of 22% Solid operational and financial performance from both Subsea and Conventional and Renewables, with Adjusted EBITDA margins of 24% and 17%, respectively Full year 2025 revenue is expected to be in a range between $6.9 and 7.1 billion while margins are expected to be between 20 and 21% Record high, quality backlog of $13.9 billion including $6.0 billion for execution in 2026 and $3.8 billion in 2027 Based on our firm backlog of contracts for execution in 2026, we expect revenue within a range of $7.0...

Continue reading

Burning Rock Reports Third Quarter 2025 Financial Results

GUANGZHOU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2025. Recent Business UpdatesTherapy SelectionPresented study results at the Cell Reports Medicine on esophageal squamous cell carcinoma in September 2025. “Integrating ctDNA with clinical response evaluation improves residual disease detection post-neoadjuvant chemoradiotherapy to support organsparing strategies and that postoperative ctDNA stratifies recurrence risk beyond pathological response to inform adjuvant immunotherapy decisions”.Early DetectionPROMISE study test results presented at The Innovation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.